Senior Director, Portfolio Strategy, Analytics & Enablement, Cardiometabolic Research
Eli Lilly and Company
Summary
The Portfolio Strategy, Analytics, & Enablement Lead for Cardiometabolic Research (CMR) will play a critical role in shaping & implementing CMR's long-term vision, and will drive high-impact initiatives that foster growth, innovation, and operational excellence. As a strategic leader with vision, this individual will develop and implement initiatives that align therapeutic areas & cross-functional teams, ensuring seamless execution of organizational priorities while anticipating and responding to industry trends. Partnering closely with the CMR Lead Team (LT), they will own the portfolio fact base, regularly assess portfolio health, frame and run priority strategic projects, and support initiatives to improve communications, culture, and capabilities across CMR. This individual will also support efforts to communicate CMR portfolio status and progress across the broader organization, including to senior leadership.
Job description
Key Responsibilities
Portfolio strategy
- Lead portfolio-level strategy projects for CMR from the initial framing of the question through analysis, synthesis, and a recommendation to the Core Leadership Team. This includes assembling the working team, driving discussions, and delivering actionable outputs.
- Develop & maintain an integrated view of the CMR portfolio across therapeutic pillars, covering development stage, therapeutic modality, target novelty, risk-reward profile, and resource load. Use this view to evaluate portfolio health & make recommendations on improvements.
- Partner with therapeutic area leaders to keep program strategies and learning plans current, and surface cross-portfolio issues such as shared scientific risks, resourcing conflicts, and unexplored white space.
- Support the long-range planning cycle by translating CMR strategic priorities into plans, metrics, and dashboards that the Core Leadership Team can manage against through the year.
- Own the metrics and dashboards that track progress against CMR strategic objectives and establish them as the shared reference point in leadership discussions.
- Track the external landscape relevant to cardiometabolic research, including competitive, scientific, and regulatory developments, and bring the implications into portfolio and planning discussions.
Organizational enablement
- Support CMR's organizational communications, including monthly CMR updates to senior leadership, and development of content & execution of CMR-wide town halls in conjunction with therapeutic area leads.
- Drive program management and change management for CMR-wide capability initiatives. One example is the Strategic Thinking program, which trains scientists to clarify program strategy, identify and prioritize key issues, and design experiments that resolve them.
- Manage recurring organizational processes and campaigns, including the President's Award proposal process.
Requirements
- Bachelor's degree in a life science, quantitative, or business field
- 6+ years of experience in pharmaceutical or biotechnology R&D with roles involving portfolio strategy, portfolio management, decision analytics, or strategy consulting serving those functions
- Experience leading cross-functional strategy projects from framing through to a leadership decision
- An advanced degree (PhD, PharmD, MS, or MBA)
- Working knowledge of drug discovery and early development in cardiometabolic disease (diabetes, obesity, cardiovascular disease, and their complications)
- Hands-on experience with portfolio analytics, including risk-adjusted valuation, probability of technical success, and resource and scenario modeling
- A track record of designing metrics and dashboards that senior leaders rely on
- The ability to draw out diverse opinions in a matrixed organization and synthesize them into a recommendation that leadership will act on
- Clear written and spoken communication to scientific and non-scientific audiences, including governance committees
- A self-motivated individual who combines scientific curiosity with an enterprise mentality and a strong grasp of business concepts
Benefits
- 401(k) Matching
- Pension
- Vacation Benefits
- Medical, Dental & Vision
- Prescription Drug Benefits
- Flexible Spending Accounts
- Life Insurance
- Death Benefits
- Time Off
- Leave of Absence
- Well-being Benefits
- Employee Assistance Program
- Fitness Benefits
- Employee Clubs and Activities
- Company Bonus
Company overview
Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.